About Cellumen
Cellumen is the leading innovator in cellular systems biology (CSB™) solutions providing the most accurate predictions of drug efficacy and safety, thus reducing failure rates and cutting development costs. Cellumen's CSB solutions are driving Discovery Toxicology by addressing the full complexity of disease and safety. Leading global organizations, such as the Mayo Clinic, Hamamatsu Photonics K.K., the EPA, FDA, NIH and top pharmaceutical companies, partner with Cellumen. Cellumen is a partner company of Safeguard Scientifics. Other investors include Novitas Capital, the Pittsburgh Life Sciences Greenhouse and Innovation Works.
Facts about Cellumen
Facts about Cellumen
- Focus : Manufacturer
- Industry : Laboratory analysis / Laboratory measurement technology
Here you will find Cellumen, Inc
Last viewed contents
Robert Riele GmbH & Co.KG - Berlin, Germany
Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
AMRI Hires Director of In Vitro Biology in Singapore
Senopsys LLC - Woburn, USA
Bayer HealthCare Diagnostics and Oxford Genome Sciences Partner in Proteomics-based Evaluation of New Biomarkers
Henniker Plasma - Runcorn, United Kingdom
Risklick - Bern, Switzerland
Ronin recruits protein 'allies' to sustain embryonic stem cell growth
Karo Bio: Karo Bio’s CEO, Fredrik Lindgren, Leaves
Cytyc Corporation - Marlborough, USA
Dipl.-Ing. Wagner Mess- und Regeltechnik GmbH - Offenbach am Main, Germany
